SonoThera

1 known investors

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound enhancing agents) to deliver genetic payloads to targeted sites in a redosable manner. The company works in genetic medicine, aiming to overcome delivery limitations related to biodistribution, safety, immunogenicity, durability, and cost.